This implies an intrinsic aggressiveness-inducing ability of IRISOE TNBC tumor cells [34], which through secreting a high level of IL-6 (and possibly others), recruit and activate MSCs to enhance their own aggressiveness by reciprocally exacerbating EP2 and EP4 activation on tumor cells through PGE2. The gene discussed is IL6; the disease is neoplasm.